We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+18.09%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$222M
AUM Growth
+$72.3M
Cap. Flow
+$53.1M
Cap. Flow %
23.89%
Top 10 Hldgs %
37.08%
Holding
85
New
24
Increased
35
Reduced
7
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 39.19%
2 Communication Services 11.73%
3 Consumer Discretionary 10.64%
4 Industrials 9.59%
5 Materials 5.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
1
Netflix
NFLX
$292B
$11.7M 5.25%
+1,242,500
New +$10.4M
RCPT
2
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$9.5M 4.28%
50,000
+13,000
+35% +$2.15M
ADPT
3
DELISTED
Adeptus Health Inc
ADPT
$8.55M 3.85%
90,000
+61,000
+210% +$4.2M
MLM icon
4
Martin Marietta Materials
MLM
$33.6B
$8.53M 3.84%
60,300
+32,300
+115% +$4.71M
META icon
5
Meta Platforms (Facebook)
META
$1.51T
$8.4M 3.78%
98,000
+25,000
+34% +$2.04M
AGN
6
DELISTED
Allergan plc
AGN
$7.94M 3.57%
26,150
+2,150
+9% +$641K
DOOR
7
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$7.85M 3.54%
112,000
+12,000
+12% +$824K
LLY icon
8
CALL
Eli Lilly
LLY
$1.07T
$7.51M 3.38%
+90,000
New +$6.86M
MYCC
9
DELISTED
ClubCorp Holdings, Inc.
MYCC
$6.46M 2.91%
270,600
+75,600
+39% +$1.67M
AMAG
10
DELISTED
AMAG Pharmaceuticals
AMAG
$5.94M 2.67%
85,950
+35,950
+72% +$2.26M
ILMN icon
11
Illumina
ILMN
$29.4B
$5.24M 2.36%
24,672
+514
+2% +$100K
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.5M 2.03%
+129,650
New +$3.96M
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.46M 2.01%
98,000
+9,000
+10% +$362K
RDUS
14
DELISTED
Radius Health, Inc.
RDUS
$4.33M 1.95%
64,000
+23,500
+58% +$1.09M
CI icon
15
Cigna
CI
$76.6B
$4.29M 1.93%
+26,500
New +$3.66M
ABBV icon
16
AbbVie
ABBV
$458B
$4.16M 1.87%
+61,850
New +$4.04M
ABMD
17
DELISTED
Abiomed Inc
ABMD
$4.08M 1.83%
62,000
+26,000
+72% +$1.73M
SSNC icon
18
SS&C Technologies
SSNC
$17.8B
$4.06M 1.83%
+130,000
New +$3.99M
DRII
19
DELISTED
DIAMOND RESORTS INTL, INC
DRII
$3.9M 1.76%
123,600
+29,100
+31% +$950K
HUM icon
20
Humana
HUM
$46.7B
$3.83M 1.72%
20,000
+9,500
+90% +$1.76M
SHPG
21
DELISTED
Shire pic
SHPG
$3.74M 1.69%
15,500
-500
-3% -$124K
UHS icon
22
Universal Health Services
UHS
$9.43B
$3.69M 1.66%
26,000
+11,500
+79% +$1.44M
NBIX icon
23
Neurocrine Biosciences
NBIX
$17.7B
$3.46M 1.56%
72,350
+21,150
+41% +$897K
TDG icon
24
TransDigm Group
TDG
$69.2B
$3.44M 1.55%
15,300
+2,925
+24% +$656K
GOOG icon
25
Alphabet (Google) Class C
GOOG
$3.9T
$3.41M 1.54%
131,000
+7,662
+6% +$205K

Similar funds

Atika Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Atika Capital Management held 85 positions worth $222M, up 48% from $150M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Atika Capital Management deployed $53.1M of net new capital in Q2 2015, opening 24 new positions and adding to 35 existing holdings. Its largest new stake was Netflix: 1,242,500 shares worth $11.7M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 40% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Esperion Therapeutics, an estimated $1.91M trimmed.

  • Atika Capital Management's largest Q2 2015 buy was Netflix: 1,242,500 shares worth $11.7M.
  • Atika Capital Management added most to Martin Marietta Materials in Q2 2015, an estimated $4.71M increase.
  • Atika Capital Management's biggest Q2 2015 reduction was Esperion Therapeutics, cutting an estimated $1.91M.
  • Atika Capital Management fully exited Advance Auto Parts in Q2 2015, selling an estimated $4.49M.
  • Atika Capital Management's ten largest holdings make up 37% of its $222M portfolio in Q2 2015.
  • Atika Capital Management opened 24 new positions and closed 19 in Q2 2015.
  • Atika Capital Management's portfolio value rose 48% quarter-over-quarter to $222M.

Based on Atika Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.